Surgical removal of submacular choroidal neovascularization: A clinicopathologic study and factors influencing visual outcomes

Ophthalmic Surgery and Lasers

Volumn 32, Issue 5, 2001, Pages 406-418

  Corey, R P ^a   Scott, I U ^a   Flynn H W , Jr ^a   Rosa R H , Jr ^a   Murray, T G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; HUMAN TISSUE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0034843617     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: Results of a randomized clinical trial
2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of two randomized clinical trials-TAP report #1
3. Radiation therapy for subfoveal neovascular membranes in age-related macular degeneration
4. External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: A review of 111 cases
5. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration
6. Translocation of the retina for management of subfoveal choroidal neovascularization in patients with age-related macular degeneration
7. Macular translocation
8. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration
9. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration
10. Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome
11. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome
12. Laser photo-coagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial
13. Functional status and quality of life measurement among ophthalmic patients
14. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration
15. Clinical experience with the surgical removal of subfoveal neovascular membranes
16. Surgical management of subfoveal choroidal neovascularization
17. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration
18. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: Stability of early visual results
19. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration
20. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration
21. Visual results after surgical removal of subfoveal choroidal neovascular membranes
22. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome
23. The surgical removal of subfoveal choroidal neovascularization. In-growth site as a predictor of visual outcome
24. Clinicopathologic correlation of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration
25. Clinicopathological correlation in exudative age related macular degeneration: Histological differentiation between classic and occult choroidal neovascularization
26. Retinal pigment epithelium destruction causes choriocapillaris atrophy
27. Clinicopathologic features of surgically excised choroidal neovascular membranes
28. Submacular surgery. Are randomized trials necessary?